GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer

This study has been terminated.
(The study was terminated following assessment of the lack of efficacy of the study product by the Independent Data monitoring Committee for the study.)
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: May 29, 2007
Last updated: September 10, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2015
  Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: August 22, 2013